The company’s shares will likely trade at a discount to rivals as it integrates the $70 billion acquisition of health insurer Aetna
Heard on the Street | CVS Deal Debate Isn’t Over |
|
| The company’s shares will likely trade at a discount to rivals as it integrates the $70 billion acquisition of health insurer Aetna |
| | |
|
|
|
LEAVE THIS BOX EMPTY |